A greater allocation to equities has not notably diminished the series’ income, though, and Vanguard Target Retirement 2025’s ...
"2024 was a strong year across the board for United as we've become the leading global airline, and we enter 2025 with demand trends continuing to accelerate, which puts us on the path to double-digit ...
Oracle's stock got a boost on Tuesday from reports about the Stargate initiative, and it closed up 7%. The formal announcement for the initiative - which featured Trump at the White House alongside ...
A group of stocks dubbed the "MAGA Seven" by MarketWatch has enjoyed significant gains since the Nov. 5 presidential election, some lifted by links to Donald Trump and others by a bullish market. Here ...
The IPC Indice de Precios Y Cotizaciones is up 248.94 points or 0.50% today to 50450.26 --Largest two-day point and percentage gain since Tuesday, Jan. 7, 2025 ...
Filling the SPR "to the top," as Trump proposes, would suggest the repurchase of roughly 300 million barrels, De Haan said, adding that if that "isn't done carefully or is done quickly, it will likely ...
The Bovespa Index is up 483.19 points or 0.39% today to 123338.34 --Up 2104.20 points or 1.74% over the last three trading days --Largest three-day point and percentage gain since Friday, Jan. 17, ...
Woodside's annual production guidance represents a 1.5% fall on 2024 output at the midpoint of the range. The Perth-based company produced a record 193.9 million BOE last year, up 4% on 2023, as it ...
Shares of technology companies rose, but not by as much as the broad market, as traders rotated into sectors more directly affected by President Donald Trump's economic proposals.
Hopes for moderation in tariff policy caused a substantial selloff in the U.S. dollar, buoying prices of dollar-denominated commodities. BHP Group posted a sharp rise in second-quarter copper ...
Enphase is the world leader in microinverter technology for rooftop solar systems.
Health-care companies rose after more promising data for the best-selling Glucagon-like Peptide inhibitor drugs. Shares of Novo Nordisk and Eli Lilly, the two leading producers of GLP-1 drugs, rallied ...